Neurocrine (NBIX) Stock Research

Friday

Neurocrine initiates Phase 1 study of NBIP-'1968

NBIX

Aug 7, 8:31 AM

Over a week ago

Neurocrine price target raised by $9 at Wedbush, here's why

NBIX

Aug 3, 8:18 AM

Neurocrine price target raised by $10 at Canaccord, here's why

NBIX

Aug 3, 7:10 AM

Neurocrine price target raised by $3 at Citi, here's why

NBIX

Jul 31, 1:33 PM

Wells Fargo recommends buying Neurocrine on weakness after solid quarter

NBIX

Jul 31, 11:11 AM

Neurocrine price target raised by $3 at Morgan Stanley

NBIX

Jul 31, 9:05 AM

Neurocrine price target raised by $20 at TD Cowen, here's why

NBIX

Jul 31, 8:56 AM

Neurocrine price target raised by $20 at Deutsche Bank

NBIX

Jul 31, 8:54 AM

Neurocrine price target raised by $15 at BofA, here's why

NBIX

Jul 31, 8:27 AM

Neurocrine price target raised by $5 at Cantor Fitzgerald, here's why

NBIX

Jul 31, 8:22 AM

Neurocrine price target raised by $4 at Needham, here's why

NBIX

Jul 31, 7:45 AM

Neurocrine price target raised by $3 at Piper Sandler, here's why

NBIX

Jul 31, 7:34 AM

Neurocrine price target raised by $27 at Stifel

NBIX

Jul 31, 7:21 AM

Neurocrine price target raised by $39 at Baird, here's why

NBIX

Jul 31, 7:21 AM

Neurocrine price target raised by $22 at Guggenheim, here's why

NBIX

Jul 31, 6:51 AM

Neurocrine raises FY26 Ingrezza net sales view to $2.825B-$2.875B

NBIX

Jul 30, 4:03 PM

Neurocrine reports Q2 adjusted EPS $2.85, consensus $1.98

NBIX

Jul 30, 4:02 PM

Neurocrine appoints Samir Siddhanti as Chief Business Officer

NBIX

Jul 21, 4:07 PM

Neurocrine price target raised by $25 at Guggenheim, here's why

NBIX

Jul 21, 8:01 AM

Neurocrine price target raised by $25 at Wells Fargo, here's why

NBIX

Jul 17, 6:23 AM

Neurocrine price target raised by $45 at Truist, here's why

NBIX

Jul 13, 9:52 AM

Neurocrine price target raised by $26 at BMO Capital, here's why

NBIX

Jul 13, 8:20 AM

Neurocrine price target raised by $9 at Wedbush, here's why

NBIX

Jul 13, 8:05 AM

Neurocrine price target raised by $12 at RBC Capital, here's why

NBIX

Jul 7, 7:21 AM

Neurocrine initiates Phase 2 study of crinecerfont

NBIX

Jul 1, 4:06 PM

Friday

Neurocrine initiates Phase 1 study of NBIP-'1968

NBIX

Aug 7, 8:31 AM

Over a week ago

Neurocrine price target raised by $9 at Wedbush, here's why

NBIX

Aug 3, 8:18 AM

Neurocrine price target raised by $10 at Canaccord, here's why

NBIX

Aug 3, 7:10 AM

Neurocrine price target raised by $3 at Citi, here's why

NBIX

Jul 31, 1:33 PM

Wells Fargo recommends buying Neurocrine on weakness after solid quarter

NBIX

Jul 31, 11:11 AM

Neurocrine price target raised by $3 at Morgan Stanley

NBIX

Jul 31, 9:05 AM

Neurocrine price target raised by $20 at TD Cowen, here's why

NBIX

Jul 31, 8:56 AM

Neurocrine price target raised by $20 at Deutsche Bank

NBIX

Jul 31, 8:54 AM

Neurocrine price target raised by $15 at BofA, here's why

NBIX

Jul 31, 8:27 AM

Neurocrine price target raised by $5 at Cantor Fitzgerald, here's why

NBIX

Jul 31, 8:22 AM

Neurocrine price target raised by $4 at Needham, here's why

NBIX

Jul 31, 7:45 AM

Neurocrine price target raised by $3 at Piper Sandler, here's why

NBIX

Jul 31, 7:34 AM

Neurocrine price target raised by $27 at Stifel

NBIX

Jul 31, 7:21 AM

Neurocrine price target raised by $39 at Baird, here's why

NBIX

Jul 31, 7:21 AM

Neurocrine price target raised by $22 at Guggenheim, here's why

NBIX

Jul 31, 6:51 AM

Neurocrine raises FY26 Ingrezza net sales view to $2.825B-$2.875B

NBIX

Jul 30, 4:03 PM

Neurocrine reports Q2 adjusted EPS $2.85, consensus $1.98

NBIX

Jul 30, 4:02 PM

Neurocrine appoints Samir Siddhanti as Chief Business Officer

NBIX

Jul 21, 4:07 PM

Neurocrine price target raised by $25 at Guggenheim, here's why

NBIX

Jul 21, 8:01 AM

Neurocrine price target raised by $25 at Wells Fargo, here's why

NBIX

Jul 17, 6:23 AM

Neurocrine price target raised by $45 at Truist, here's why

NBIX

Jul 13, 9:52 AM

Neurocrine price target raised by $26 at BMO Capital, here's why

NBIX

Jul 13, 8:20 AM

Neurocrine price target raised by $9 at Wedbush, here's why

NBIX

Jul 13, 8:05 AM

Neurocrine price target raised by $12 at RBC Capital, here's why

NBIX

Jul 7, 7:21 AM

Neurocrine initiates Phase 2 study of crinecerfont

NBIX

Jul 1, 4:06 PM

Company News

Charts